Developmental role for endocannabinoid signaling in regulating glucose metabolism and growth

Diabetes

Volumn 62, Issue 7, 2013, Pages 2359-2367

  Li, Zhiying ^a   Schmidt, Sarah F ^a   Friedman, Jeffrey M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCANNABINOID; GLUCOSE; LEPTIN; MESSENGER RNA; RECOMBINANT HUMAN INSULIN; RECOMBINANT SOMATOMEDIN C; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; INSULIN; LEPTIN RECEPTOR; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; RIMONABANT; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY WEIGHT; DUAL ENERGY X RAY ABSORPTIOMETRY; FOOD INTAKE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; INSULIN RELEASE; INSULIN TOLERANCE TEST; METABOLIC REGULATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; ANIMAL; DRUG EFFECT; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CANNABINOID RECEPTOR ANTAGONISTS; ENDOCANNABINOIDS; GLUCOSE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LIVER; MICE; MICE, KNOCKOUT; OBESITY; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION;

EID: 84883668610     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0901     Document Type: Article

References (22)

1. Allen Institute for Brain Science. Allen Brain Atlas data portal [Internet], 2013. Available from http://www.brain-map.org. Accessed 8 March 2013
2. Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003;83:1017-1066
3. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 2009;89:309- 380
4. Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science 2002;296:678- 682
5. Di Marzo V, Goparaju SK, Wang L et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001;410:822-825
6. Cota D, Marsicano G, Tschöp M, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003;112:423-431
7. Quarta C, Bellocchio L, Mancini G, et al. CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metab 2010;11:273-285
8. Nogueiras R, Veyrat-Durebex C, Suchanek PM, et al. Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes 2008;57:2977-2991
9. Osei-Hyiaman D, DePetrillo M, Pacher P, et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005;115:1298-1305
10. Osei-Hyiaman D, Liu J, Zhou L, et al. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 2008;118:3160-3169
11. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to dietinduced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 2004;28:640-648
12. Steiner H, Bonner TI, Zimmer AM, Kitai ST, Zimmer A. Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice. Proc Natl Acad Sci U S A 1999;96:5786-5790
13. Charlton HM. Mouse mutants as models in endocrine research. Q J Exp Physiol 1984;69:655-676
14. Bermúdez-Siva FJ, Serrano A, Diaz-Molina FJ, et al. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. Eur J Pharmacol 2006;531:282-284
15. Song D, Bandsma RH, Xiao C, et al. Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. Diabetologia 2011;54:1181- 1189
16. Bajzer M, Olivieri M, Haas MK, et al. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice. Diabetologia 2011;54:3121-3131
17. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered 1996;4:101
18. Goodman HM. Basic Medical Endocrinology. 4th ed. San Diego, Academic
19. Al-Massadi O, Gabellieri E, Trujillo ML, et al. Peripheral endocannabinoid system- mediated actions of rimonabant on growth hormone secretion are ghrelin-dependent. J Neuroendocrinol 2010;22:1127-1136
20. Rosenstock J, Hollander P, Chevalier S, Iranmanesh A; SERENADE Study Group. SERENADE: The Study Evaluating Rimonabant Efficacy in Drugnaive Diabetic Patients: effects of monotherapy with rimonabant, the first iselective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes. Diabetes Care 2008;31:2169- 2176
21. Li C, Bowe JE, Jones PM, Persaud SJ. Expression and function of cannabinoid receptors in mouse islets. Islets 2010;2:293-302
22. Pagano C, Pilon C, Calcagno A, et al. The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. J Clin Endocrinol Metab 2007;92:4810-4819